Defendants (collectively referred to as “Bayer”) have petitioned for leave to appeal the remand orders issued by the district court in the four above-captioned casеs. In five separate, mostly identical complaints in state court, plaintiffs sued Bayer for personal injuries they allege were caused by Trasylol, a prescription medication manufaсtured by Bayer. Defendants removed, invoking the “mass action” provision of the Class Action Fairness Act (“CAFA”), which allows the removal of cases joining the claims of at least 100 plaintiffs that otherwise meеt CAFA’s jurisdictional requirements. The district court remanded four of the five cases because they contained fewer than 100 plaintiffs (in the fifth case plaintiffs meant to include 99 plaintiffs, but actually named two-coexecutors in the same paragraph for a total of 100 plaintiffs). Bayer asks us to grant its petitions for review in the four cases remanded to state court and hold that (1) plaintiffs cannot avoid federal diversity jurisdiction by carving their filings into five separate pleadings, and (2) there is diversity jurisdiction over most plaintiffs claims because the claims of the small number of non-diverse plaintiffs were fraudulently misjoined and should be severed. Because we agree with the district court on the first question, we conclude that we are without jurisdiction to reach the second.
In August and September of 2009, рlaintiffs’ counsel filed in St. Clair County, Illinois, claims on behalf of 57 unrelated plaintiffs, dividing the claims between four virtually identical complaints, using verbatim language, alleging that the plaintiffs (or their decedents) sufferеd injuries as a result of being administered Trasylol during heart surgery. Bayer removed, invoking the district court’s diversity jurisdiction over the diverse plaintiffs’ claims by arguing that the few non-diverse plaintiffs had been fraudulently misjoined. The district court remanded sua sponte.
After remand to St. Clair County, plaintiffs’ counsel amended the complaints to add 111 new plaintiffs, spread across the four existing suits. This resulted in a total of 100 plaintiffs in Gilmore, 1 5 in Brown, 45 in Bancroft, and 18 in Lecker. Plaintiffs’ counsel also filed a fifth complaint, Anderson, naming three plaintiffs, one of whom was non-diverse. Defendants once again removed. The district court remanded Bancroft, Brown, Lecker, and Anderson, rejecting defendants’ argument that they should be treated as a single mass action and defendants’ alternative argument that the non-diverse plaintiffs should have been severed from the action as fraudulently misjoined. Defendants then filed this petition for permission to appeal under 28 U.S.C. § 1453(c), a provision of CAFA that creates an exception for class actions to the general rule that remand orders are not reviewable. See id.; 28 U.S.C. § 1447(d).
Bayer first argues that plaintiffs’ cases meet CAFA’s definition of a “mass action” and thus the district court erred in remanding the cases. 28 U.S.C. § 1332(d)(ll)(B)(i) defines a mass action as “any civil action ... in which the monetary relief claims of 100 or more persons are prоposed to be tried jointly on the ground that the plaintiffs’ claims involve common questions of law or fact.” Under CAFA, such mass actions “shall be deemed to be a class action” removable to federal court, so *393 long as CAFA’s other jurisdictional requirements are met. Id. § 1332(d)(ll)(A). There is no dispute that the other requirements — amount in controversy and minimal diversity' — 'are met in each of the four cases that Bayer appealed.
Of course, none of the instant four cases actually involve the claims of more than 100 plaintiffs. Bayer, however, urges us not to place “too much weight on form” in the CAFA context.
See Marshall v. H & R Block Tax Servs., Inc.,
Freeman,
however, did not address the mass action provision of CAFA. This distinction is important because CAFA states that “the term ‘mass action’ shall nоt include any civil action in which the claims are joined upon motion of a defendant.” 28 U.S.C. § 1332(d)(ll)(B)(ii)(II). By excluding cases in which the claims were consolidated on a defendant’s motion, Congress appеars to have contemplated that some cases which could have been brought as a mass action would, because of the way in which the plaintiffs chose to structure their claims, remain outside of CAFA’s grant of jurisdiction. This is not necessarily anomalous; after all, the general rule in a diversity case is that “plaintiffs as masters of the complaint may include (or omit) claims or parties in оrder to determine the forum.”
See Garbie v. DaimlerChrysler Corp.,
The only appellate court to have addressed an argument similar to Bayer’s has rejected its approach. In
Tanoh v. Dow Chemical Co.,
We agree with our colleagues on the Ninth Circuit. The mass action provision gives plaintiffs the choice to file separate actions that do not qualify for CAFA jurisdiction. The instant cases contain fewer than 100 plaintiffs and thus are not removable under the plain language of the statute. Bayer’s argument that thеse sep *394 arate lawsuits be treated as one action is tantamount to a request to consolidate them — a request that Congress has explicitly stated cannot become a basis fоr removal as a mass action.
Of course, subsequent action by the plaintiffs in state court might render these claims removable.
See Bullard v. Burlington Northern Santa Fe Railway Co.,
Finding no federal jurisdiction under CAFA, we turn to defendants’ altеrnative argument for diversity jurisdiction, fraudulent misjoinder. Before reaching the merits of this argument, however, we must consider plaintiffs’ argument that we are without appellate jurisdiction to hear it.
Typically, federal courts of appeal are barred from reviewing district court orders remanding removed cases to state court.
See
28 U.S.C. § 1447(d). However, an exception exists when a party appeals “from an order granting or denying a motion to remand a class action to the State court from which it was removed.” 28 U.S.C. § 1453(c). In
Brill v. Countrywide Home Loans, Inc.,
We have, however, an indepеndent duty to examine the basis for our jurisdiction, and this case differs from
Bñll
in one important respect. In
Bñll,
there was never any dispute about whether the state court case was a class action. Instead, we were confronted with both CAFA and nonCAFA theories of federal subject-matter jurisdiction over a particular class action, and concluded that we had the jurisdiction to address both arguments.
*395 Defendants’ petition for leаve to appeal under 28 U.S.C. § 1453(c) is Denied.
Notes
. Because it joined the claims of 100 or more plaintiffs,
Gilmore v. Bayer Corp.,
No. 09-986-GPM,
. Like the Ninth Circuit in
Tanoh,
we express no opinion as to whether a state court’s sua sponte joinder of claims might allow a defendant to remove separately filed state court claims to federal court as a single “mass action.”
